Healthcare Technology Report March 1, 2023
A half-decade after launching its Oncology Center of Excellence (OCE), the FDA is signaling an overall slowdown of new project green lights in the interest of bolstering existing programs and bringing modernized methodology to its clinical trials. Specifically, four extant or entirely new programs will be ramped up with this renewed focus to help with much-needed modernization.
It’s not the first time the fairly young organization has had the word “modern” plastered all over its press releases. Last year, as...
Today's Sponsors
Today's Sponsor